
Inflammatory bowel disease is a chronic gastrointestinal condition that affects physical health, psychosocial functioning, and quality of life. Body image dissatisfaction is a prevalent yet underrecognized concern among adults living with inflammatory bowel disease and has important implications for nursing care. The purpose of this integrative literature review was to synthesize existing evidence on body image dissatisfaction in adults with inflammatory bowel disease and examine its relevance for nursing practice. A systematic search of four electronic databases was conducted in December 2025, and 20 studies met the inclusion criteria. Both qualitative and quantitative studies were critically appraised and analyzed. Four key themes emerged: altered body perception, psychosocial effects, gender and societal influences, and symptom burden with associated treatments. Findings demonstrate that body image dissatisfaction extends beyond physical appearance and is closely linked to emotional distress, social withdrawal, stigma, and reduced health-related quality of life. Symptoms, medical treatments, and surgical interventions further contribute to negative body perception. Nurses are uniquely positioned to identify and address body image concerns through holistic assessment, patient education, emotional support, and advocacy for multidisciplinary care. Integrating body image assessment into routine nursing practice may improve patient engagement, psychosocial well-being, treatment adherence, and overall quality of life for individuals living with inflammatory bowel disease.
Discomfort and anxiety are key factors during upper gastrointestinal endoscopy (UGIE), impacting patient experience and safety. However, health care professionals often misjudge these levels, which can affect the procedure’s outcome. This study aimed to compare patient-reported discomfort and anxiety during UGIE with health care professionals’ assessments. A total of 229 patient–endoscopic assistant–endoscopist triads were enrolled in the study. Discomfort and anxiety were measured on an 11-point numerical rating scale. Patients rated their expected level of discomfort at 5.5 (95% confidence interval: 5.2–5.8) and their recalled discomfort at 4.9 (95% confidence interval: 4.5–5.3). Gender differences were observed in expected discomfort levels, but not in recalled discomfort. The mean anxiety score before UGIE was 4.2 ( SD 3.0). Patients generally rated their discomfort during UGIE and anxiety before the procedure higher than health care professionals did, with significant interindividual variation. Despite this, the majority of patients ( n = 202, 88.2%) were willing to undergo UGIE again. The study revealed significant discrepancies between patient and professional assessments of discomfort and anxiety, likely due to individual variability. Delivering person-centered care during UGIE requires advanced skills to address these differences, emphasizing the need for ongoing skill development in clinicians.
Persons with decompensated cirrhosis are influenced not only physically but also psychologically and socially, as they are repeatedly hospitalized and discharged due to various physical symptoms. This study aimed to clarify the experiences of individuals with decompensated cirrhosis. Six individuals with cirrhosis after chronic hepatitis, treated as outpatients or inpatients at the Hepatology Department of two medical facilities by full-time hepatologists, were included in semi-structured interviews. The results were analyzed individually and comprehensively using a qualitative synthesis method (KJ method). The management of individuals with decompensated cirrhosis included "continued management" and "management that prioritizes daily life." Management was supported by two aspects: "recuperation supported by a connection with others" and "recuperation far from others." Furthermore, despite managing their disease and being conscious of the gradual progression of their condition, participants with decompensated cirrhosis oscillated between their "reluctance to accept life with illness" and "unrelieved anxiety about their future"; their "elusive body" influenced their management and emotions in their daily living. Although individuals with decompensated cirrhosis have managed their illness for many years, they may not fully understand the evolving physical changes in their bodies. Additionally, they may experience growing concerns about the future.
Due to its specific disease characteristics, the diagnosis and treatment of pancreatic cancer often requires patients to repeatedly travel between their home and medical institutions due to the ineffective management of symptoms, cachexia, and other issues, thus incurring significant time, costs, and financial investment in their quest for medical treatment. The use of mobile health (mHealth) technology has alleviated this predicament, at least to a certain extent. The aim of this article is to discuss the current status and issues faced when using mHealth in the disease management of patients with pancreatic cancer. We summarize the current new advances in mHealth in the field of pancreatic cancer disease management and analyze barriers to the widespread adoption of mHealth technologies. mHealth technology makes the various stages of disease management more convenient and efficient for pancreatic cancer patients. It is hoped that relevant legislation and regulations will be developed and that narrowing the "digital divide" will be more conducive to the development of mHealth models in pancreatic cancer patients.